Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 16.38% is 12% above its 5-year average of 14.58%, near the high end of its 5-year range (-2.38%–23.07%).
As of the fiscal period ended Wednesday, December 31, 2025. 157.14% above its 12-month average of 6.37%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
16.38%
RETURN ON ASSETS (ROA) AVG TTM
6.37%
RETURN ON ASSETS (ROA) AVG 3Y
11.74%
RETURN ON ASSETS (ROA) AVG 5Y
14.58%
RETURN ON ASSETS (ROA) AVG 10Y
10.58%
RETURN ON ASSETS (ROA) AVG 15Y
4.20%
RETURN ON ASSETS (ROA) AVG 20Y
-8.81%
CURRENT VS TTM AVG
+157.14%
CURRENT VS 3Y AVG
+39.52%
CURRENT VS 5Y AVG
+12.36%
CURRENT VS 10Y AVG
+54.79%
CURRENT VS 15Y AVG
+289.63%
CURRENT VS 20Y AVG
+286.00%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+232.25%
vs the sector median at left
Vertex Pharmaceuticals Incorporated
Market Cap
$121.16B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$119.53B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$126.60B
Return on Assets (ROA)
7.21%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$126.79B
Return on Assets (ROA)
8.41%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$134.62B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$106.51B
Return on Assets (ROA)
5.16%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$137.47B
Return on Assets (ROA)
1.16%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$139.86B
Return on Assets (ROA)
3.61%
TTM Avg
3.75%
3Y Avg
6.08%
5Y Avg
7.08%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $121.16B | 16.38% | 6.37% | 11.74% | 14.58% |
| Intuitive Surgical, Inc. (ISRG)vs › | $119.53B | 15.04% | 13.09% | 12.00% | 11.68% |
| Stryker Corporation (SYK)vs › | $126.60B | 7.21% | 6.88% | 7.02% | 6.41% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 8.41% | -0.92% | 3.28% | 1.99% |
| Danaher Corporation (DHR)vs › | $134.62B | 4.33% | 4.68% | 5.89% | 6.01% |
| Medtronic plc (MDT)vs › | $106.51B | 5.16% | 5.13% | 4.62% | 4.65% |
| CVS Health Corp. (CVS)vs › | $137.47B | 1.16% | 1.25% | 1.93% | 2.38% |
| GSK plc (GSK)vs › | $103.60B | 7.15% | 6.85% | 11.28% | 9.07% |
| Pfizer Inc. (PFE)vs › | $139.86B | 3.61% | 3.75% | 6.08% | 7.08% |
| McKesson Corporation (MCK)vs › | $98.45B | 5.78% | 5.08% | 5.08% | 2.52% |
ROA
16.4%
ROE
22.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 15.12% |
| 2024-12-31 | -2.38% |
| 2023-12-31 | 15.92% |
| 2022-12-31 | 18.30% |
| 2021-12-31 | 17.44% |
| 2020-12-31 | 23.07% |
| 2019-12-31 | 14.15% |
| 2018-12-31 | 33.57% |
| 2017-12-31 | 7.43% |
| 2016-12-31 | -3.87% |
| 2015-12-31 | -22.35% |
| 2014-12-31 | -31.61% |
| 2013-12-31 | -19.19% |
| 2012-12-31 | -3.88% |
| 2011-12-31 | 1.34% |
| 2010-12-31 | -43.74% |
| 2009-12-31 | -32.81% |
| 2008-12-31 | -46.90% |
| 2007-12-31 | -65.05% |
| 2006-12-31 | -22.45% |
| 2005-12-31 | -37.05% |
| 2004-12-31 | -30.48% |
| 2003-12-31 | -27.16% |
| 2002-12-31 | -13.32% |
| 2001-12-31 | -7.16% |
| 2000-12-31 | -5.13% |
| 1999-12-31 | -17.64% |
| 1998-12-31 | -12.43% |
| 1997-12-31 | -6.70% |
| 1996-12-31 | -27.87% |
